Gibson Dunn Represented Neurogene on $143.7 Million Offering of Common Stock and Pre-Funded Warrants
July 17, 2026
July 17, 2026
LOS ANGELES, California, July 17 [Category: BizLaw/Legal] -- Gibson, Dunn and Crutcher, a law firm, issued the following news:
* * *
Gibson Dunn Represented Neurogene on $143.7 Million Offering of Common Stock and Pre-Funded Warrants
*
Gibson Dunn represented Neurogene Inc., a clinical-stage biotechnology company focused on developing life-changing genetic medicines for people and their families impacted by devastating neurological diseases, in . . .
* * *
Gibson Dunn Represented Neurogene on $143.7 Million Offering of Common Stock and Pre-Funded Warrants
*
Gibson Dunn represented Neurogene Inc., a clinical-stage biotechnology company focused on developing life-changing genetic medicines for people and their families impacted by devastating neurological diseases, in . . .